The global dialysis market, valued at USD 116.0 billion in 2023, is projected to reach USD 198.1 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.5%. This growth is primarily driven by the increasing prevalence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD), necessitating long-term dialysis treatment. The hemodialysis segment dominates the market, accounting for approximately 67.3% of the market share in 2023 due to its efficiency in balancing essential blood components and its shorter treatment time compared to peritoneal dialysis.
Several factors contribute to the market’s expansion, including advancements in dialysis equipment and services, improved healthcare infrastructure, and favorable reimbursement policies. For instance, the development of state-of-the-art dialysis centers and the introduction of innovative devices like the Fist Assist for vein enlargement before fistula placement have enhanced treatment options for patients.
However, the market faces challenges such as complications associated with dialysis treatments, including infections and cardiovascular issues, and the preference for kidney transplants among some patients. Despite these challenges, the increasing demand for home dialysis, particularly peritoneal dialysis, which offers greater patient independence and cost-effectiveness, is expected to drive market growth.
Recent developments include the opening of new dialysis centers and the launch of advanced home dialysis products, which are expected to further boost the market. For example, Baxter’s launch of Sharesource Analytics 1.0, a digital health module for home-based peritoneal dialysis, exemplifies the ongoing innovation in the sector.
Key Takeaways
- Dialysis Market size is projected to reach USD 198.1 Billion by 2033 from USD 116.0 Billion in 2023.
- The market is expected to grow at a CAGR of 5.5% from 2024 to 2033.
- The hemodialysis segment dominates with a market share exceeding 67.3%.
- Services segment held 41.3% market share in 2023, driven by providers focusing on high-quality patient care.
- Dialysis centers and hospitals commanded 57.8% market share in 2023, aided by favorable reimbursement for renal treatments.
- North America is projected to hold a 31.6% market share, generating USD 36.6 Billion in revenue.
- Key market drivers include the rising prevalence of chronic kidney diseases and increased access to hemodialysis facilities.
- The growing preference for home-based dialysis products also drives market growth.
- Key market restraints include the rising number of kidney transplants and complications related to dialysis.
- Emerging markets in Asia Pacific and RoW offer significant growth opportunities for dialysis market players.
Get Sample PDF Report: https://market.us/report/dialysis-market/request-sample/
Dialysis Market Key Segments
By Dialysis Type
- Hemodialysis
- Peritoneal Dialysis
By Product & Services
- Equipment
- Consumables
- Dialysis Drugs
- Services
By End-User
- Dialysis Centers & Hospitals
- Home Care
- Other End-Users
Key Regions
- North America (The US, Canada, Mexico)
- Western Europe (Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, Rest of Western Europe)
- Eastern Europe (Russia, Poland, The Czech Republic, Greece, Rest of Eastern Europe)
- APAC (China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Rest of APAC)
- Latin America (Brazil, Colombia, Chile, Argentina, Costa Rica, Rest of Latin America)
- Middle East & Africa (Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, Rest of MEA)
Buy Directly: https://market.us/purchase-report/?report_id=101342
Key Players Analysis
B. Braun, through its subsidiary B. Braun Avitum, provides a comprehensive range of dialysis products and services. The company focuses on both in-center and home dialysis treatments. B. Braun Avitum manages numerous dialysis centers globally, including significant operations in the UK and the Philippines. In the UK, B. Braun Avitum collaborates with the NHS to deliver hemodialysis and peritoneal dialysis therapies, aiming to enhance home dialysis uptake. The company’s innovative Dialog+ machine supports high-quality treatment for patients, while partnerships like the one with Physidia are set to expand home dialysis options significantly.
Baxter International Inc. is a prominent player in the dialysis sector, offering a wide range of products and therapies for renal care. Baxter’s portfolio includes hemodialysis (HD) and peritoneal dialysis (PD) solutions designed to meet the diverse needs of patients. The company is known for its commitment to innovation and improving patient outcomes through advanced technologies and services. Baxter’s PD therapies, such as the Automated Peritoneal Dialysis (APD) systems, provide patients with greater flexibility and independence, which are critical for improving the quality of life for those with chronic kidney disease.
Fresenius Medical Care is the largest provider of dialysis products and services worldwide. The company operates a network of over 4,000 dialysis clinics, serving more than 345,000 patients globally. Fresenius offers a comprehensive range of dialysis equipment, including machines and disposable products, and provides in-center dialysis, home dialysis, and transplant services. Their focus on patient-centric care and continuous innovation has positioned them as a leader in the market, with significant investments in research and development to advance dialysis technology and improve patient outcomes.
Asahi Kasei Corporation is a key player in the dialysis market, particularly known for its development of advanced membrane technology used in dialyzers. The company’s polysulfone membranes are widely recognized for their superior performance in removing toxins from the blood during dialysis. Asahi Kasei also offers a range of dialysis machines and related products that cater to both in-center and home dialysis settings. Their commitment to innovation and quality has helped them establish a strong presence in the global dialysis market, contributing to the advancement of renal care.
Becton Dickinson (BD) is an influential company in the medical technology sector, providing essential products and solutions for dialysis care. BD’s offerings include a variety of devices used in dialysis procedures, such as catheters and vascular access products. The company focuses on enhancing the safety and efficiency of dialysis treatments through its innovative solutions. BD’s comprehensive approach to dialysis care, combined with its extensive experience in medical technology, enables it to deliver high-quality products that support better patient outcomes and streamline clinical workflows.
Dialysis Market Key Players:
- B. Braun
- Baxter International Inc.
- Fresenius Medical Care AG & Co. KGaA
- Asahi Kasei Corporation
- Becton Dickinson and Company
- DaVita Inc.
- Medtronic plc
- Nipro Corporation
- NIKKISO CO. LTD.
- Satellite Healthcare Inc.
- Toray Industries Inc.
- Other Key Players
Dialysis Market Report Scope >> Market Value (2023): USD 110 Billion || Forecast Revenue (2033): USD 185 Billion || CAGR (2024-2033): 5.5% || Base Year Estimation: 2023 || Historic Period: 2019-2022 || Forecast Period: 2024-2033.
Inquire More about report: https://market.us/report/dialysis-market/#inquiry
About Market.US
Market.US is renowned for its comprehensive market research and analysis, providing customized and syndicated reports to a global clientele. Specializing in a variety of sectors, they offer strategic insights and detailed market forecasts, assisting businesses in making informed decisions. With a focus on innovation and accuracy, Market.US supports clients in over 126 countries, and maintains a strong repeat customer rate, underscoring their commitment to quality and client satisfaction. Their team excels in delivering exceptional research services, ensuring that no detail is overlooked in any target market.
Contact Details
Market.us (Powered By Prudour Pvt. Ltd.)
Contact No: +1 718 618 4351.
Email: [email protected]
Blog: https://medicalmarketreport.com/
View More Trending Reports
Regenerative Medicine Market Will Grow Nearly USD 194.9 Billion At A Rate Of 19.4% By 2033
Next Generation Sequencing Market Will Reach USD 29.7 Billion By 2033 And Hit Around 14.6% CAGR
Companion Diagnostics Market Outlook: Expected To Expand To USD 4,786 Million Upholding A 7.1% CAGR
Corporate Wellness Market Projected To Reach USD 100.8 Billion By 2033, With CAGR Of 6.1%